*** Conﬁdential Treatment Requested and the Redacted Material has been separately ﬁled with the Commission.
of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be
necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment. Without limiting the generality of
the foregoing, the Company will (i) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (ii) use its commercially reasonable
efforts to obtain, make or file (as applicable) any consents, approvals, orders, waivers, exemptions, authorizations, registrations,
declarations, filings, qualifications, certifications, notices, applications, reports or waiting period expirations from, to or with any
regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant,
including obtaining Stockholder Approval if necessary.
5. Expiration . This Warrant and the right to purchase Warrant Shares upon exercise hereof shall expire at 11:59 pm,
New York City time, on July 24, 2024 (such date, as it may be extended pursuant to Section 3(e)(i), the “ Expiration Date ”).
6. Notices of Record Date, etc . In case of:
(a) any Change of Control, any Fundamental Change or any other consolidation or merger of
the Company, capital reorganization of the Company, or reclassification or recapitalization of the Capital Stock of the Company, in each
case, in any one transaction or a series of related transactions, or
(b) the voluntary or involuntary dissolution, liquidation or winding-up of the Company, or
(c) any grant by the Company to the holders of its Common Stock or any other Company
security then issuable upon exercise of this Warrant of (or the taking by the Company of a record of such holders for the purpose of
determining their entitlement to receive) any dividend or other distribution or any right to subscribe for, purchase, receive or otherwise
acquire any shares of Capital Stock of any class or any option, warrant or security convertible into or exercisable or exchangeable
therefor, then, and in each such case, or
(d) any reduction in the number of outstanding shares of its Common Stock or any other
Company security then issuable upon exercise of this Warrant, whether as a result of repurchases by the Company or otherwise:
the Company will mail or cause to be mailed to the Holder of this Warrant a notice specifying, as the case may be, the estimated effective
date on which such Change of Control, Fundamental Change, consolidation, merger, reorganization, reclassification, recapitalization,
dissolution, liquidation, winding-up, dividend, distribution, other grant of rights or reduction is to take place, and the time, if any is to be
fixed, as of which the holders of record of the Common Stock shall be entitled to exchange their shares for securities or other property
deliverable upon such Change of Control, Fundamental Change, consolidation, merger, reorganization, reclassification, recapitalization,
dissolution, liquidation or winding-up or to receive (or be entitled to receive) such dividend, distribution or other grant of rights. Such
notice shall be mailed at least ten (10) Business Days prior to the record date or effective date for the event specified in such notice. Such
notice